All About Peps
Sexual Health

PT-141

Also known as: Bremelanotide, Vyleesi

A melanocortin receptor agonist, FDA-approved by prescription (as Vyleesi) for hypoactive sexual desire disorder in premenopausal women, and used off-label/via research channels for libido in both sexes.

Check current pricing at Amino Club

Affiliate link — shop PT-141. We may earn a commission at no cost to you.

What Is PT-141?

TL;DR: PT-141 (bremelanotide) is FDA-approved as Vyleesi for low sexual desire in premenopausal women, working through brain pathways rather than blood flow — off-label and non-prescription use in men exists but isn’t the approved, evidence-backed indication.

PT-141, known generically as bremelanotide, is a peptide that activates melanocortin receptors (specifically MC4R) in the central nervous system. It was originally derived during research into Melanotan II, a tanning peptide, after researchers observed that it also increased sexual arousal in study participants — leading to its separate development as a treatment for low sexual desire.

How It Works

Rather than increasing blood flow to sexual organs (the mechanism behind drugs like sildenafil/Viagra), PT-141 acts on melanocortin receptors in the brain that are involved in regulating sexual arousal and desire, which is why it’s discussed as a complementary or alternative option for people whose primary concern is desire rather than blood-flow-related function.

Who Uses It and Why

Its approved use is narrow — premenopausal women with a specific diagnosis of hypoactive sexual desire disorder — but its broader popularity in the peptide community comes from off-label interest from men and postmenopausal women exploring effects on libido, obtained through both prescription (off-label) and non-prescription research-chemical channels.

Reported Benefits

Increased sexual desire (FDA-approved indication)

PT-141 is FDA-approved as Vyleesi specifically to treat acquired, generalized hypoactive sexual desire disorder in premenopausal women, based on clinical trials showing improvement in desire and reduction in related distress compared to placebo.

Works through the brain, not blood flow

Unlike PDE5 inhibitors (like sildenafil) that work by increasing blood flow, PT-141 acts on melanocortin receptors in the central nervous system, which is the proposed reason it's discussed as an option for people whose primary issue is low desire rather than blood-flow-related dysfunction.

Off-label interest for erectile function in men

Because bremelanotide's precursor (Melanotan II) showed erectile effects in early trials, PT-141 is used off-label and through research channels by some men seeking effects on arousal and erectile function, though this is outside its approved indication and evidence base.

How PT-141 Is Typically Used

Common forms

  • Subcutaneous injection (Vyleesi auto-injector, prescription)
  • Subcutaneous injection from research-chemical vials (non-prescription, unregulated)

Typical protocol discussed in the community

The FDA-approved Vyleesi dose is 1.75 mg injected as needed at least 45 minutes before anticipated sexual activity, with a maximum of one dose in 24 hours and no more than 8 doses per month. Off-label/community protocols for other uses vary and aren't clinically validated.

Notes

Vyleesi carries specific prescribing guidance, including temporary blood pressure increases after dosing and a recommendation not to use more than the labeled frequency. Non-prescription sourcing bypasses this safety monitoring entirely.

Legal Status

FDA-approved as a prescription medication (Vyleesi) specifically for acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. It is also sold by research chemical suppliers and used off-label in men and outside its approved indication, which falls outside FDA-regulated use.

Potential Side Effects

Frequently Asked Questions

Is PT-141 the same as Melanotan II?+

They're related but distinct. PT-141 (bremelanotide) was actually developed as a metabolite/derivative of Melanotan II during research into tanning peptides, when researchers noticed its effects on arousal. PT-141 is more selective for the sexual-desire-related pathway, while Melanotan II more strongly drives skin pigmentation.

Does PT-141 work for men?+

It's only FDA-approved for hypoactive sexual desire disorder in premenopausal women. Men use it off-label or through research channels reporting effects on libido and erectile function, but this isn't the approved, clinically validated use.

Why does PT-141 cause nausea?+

It's a very common side effect tied to melanocortin receptor activation in the brain, which is also involved in regulating nausea; it was one of the most frequently reported side effects in Vyleesi's clinical trials, especially with the first few doses.

Check current pricing at Amino Club

Affiliate link — shop PT-141. We may earn a commission at no cost to you.

Related Peptides

Melanotan II